Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis

被引：0
|
作者：
Michael V. Chiorean
Jessica R. Allegretti
Puza P. Sharma
Benjamin Chastek
Leonardo Salese
Elizabeth J. Bell
Jesse Peterson-Brandt
Joseph C. Cappelleri
Xiang Guo
Nabeel Khan
机构：
[1] Swedish Medical Center,Perelman School of Medicine
[2] Brigham and Women’s Hospital,undefined
[3] Pfizer Inc,undefined
[4] Optum Life Sciences,undefined
[5] HEOR,undefined
[6] Pfizer Inc,undefined
[7] Pfizer Inc,undefined
[8] University of Pennsylvania,undefined
来源：
BMC Gastroenterology | / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Tofacitinib for Rescue Therapy in Acute Severe Ulcerative Colitis: A Real-world Experience
    Kotwani, Prashant
    Terdiman, Jonathan
    Lewin, Sara
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (07): : 1026 - 1028
  • [22] Real-world tofacitinib effectiveness and safety in patients with refractory ulcerative colitis
    Lair-Mehiri, L.
    Stefanescu, C.
    Vaysse, T.
    Laharie, D.
    Roblin, X.
    Rosa, I.
    Treton, X.
    Abitbol, V.
    Amiot, A.
    Bouguen, G.
    Dib, N.
    Fumery, M.
    Pariente, B.
    Carbonnel, F.
    Peryn-Biroulet, L.
    Simon, M.
    Viennot, S.
    Bouhnik, Y.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S478 - S479
  • [23] Ulcerative colitis: Tofacitinib under real-world conditions
    Kessing, Richard
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2023, 61 (12): : 1565 - +
  • [24] Editorial: real-world safety of tofacitinib in ulcerative colitis
    Taxonera, Carlos
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (03) : 368 - 369
  • [25] Assessment of the real-world effectiveness of upadacitinib in patients with moderate-severe ulcerative colitis in a global real-world setting
    Seidelin, J. B.
    Marin-Jimenez, I
    Dawod, F.
    Lukanova, R.
    Jones, W.
    Morriset, P.
    Sharma, D.
    Siegel, C.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1261 - i1263
  • [26] TOFACITINIB IMPROVES CLINICAL DISEASE ACTIVITY IN A REAL-WORLD POPULATION OF PATIENTS WITH MODERATE-SEVERE ULCERATIVE COLITIS AND CROHN'S DISEASE
    Clark-Snustad, Kindra D.
    Singla, Anand
    Lee, Scott D.
    GASTROENTEROLOGY, 2019, 156 (06) : S664 - S664
  • [27] Tofacitinib in Acute Severe Ulcerative Colitis-A Real-World Tertiary Center Experience
    Honap, Sailish
    Pavlidis, Polychronis
    Ray, Shuvra
    Sharma, Esha
    Anderson, Simon
    Sanderson, Jeremy D.
    Mawdsley, Joel
    Samaan, Mark A.
    Irving, Peter M.
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (11) : E147 - E149
  • [28] Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis
    Danese, Silvio
    D'Amico, Ferdinando
    Bonovas, Stefanos
    Peyrin-Biroulet, Laurent
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (10) : 2106 - 2112
  • [29] Real-world evidence on treatment switching in patients with moderate-to-severe ulcerative colitis: a systematic review of literature
    Singh, H.
    Wilson, L.
    Pandey, A.
    Tencer, 'T.
    Kumar, J.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S511 - S512
  • [30] Real-World Evidence on the Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis in Lebanon
    Sharara, Ala I.
    Alrazim, Ayman
    Saniour, Philippe
    Daniel, Fady
    Rached, Antoine Abou
    Bahr, Abbas
    Azar, Cecilio
    Geagea, Antoine
    Ghoubar, Marcelle
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S858 - S859
12345